குவாண்டம் பார்மா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from குவாண்டம் பார்மா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In குவாண்டம் பார்மா Today - Breaking & Trending Today

Investegate |Kitwave Group plc Announcements | Kitwave Group plc: Placing and Proposed Admission to Trading on AIM


 
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.
 
This announcement is not an admission document or a prospectus and does not constitute or form part of an offer to sell or issue or a solicitation of an offer to subscribe for or buy any securities nor should it be relied upon in connection with any contract or commitment whatsoever. Investors should not purchase or subscribe for any transferable securities referred to in this announcement except in compliance with applicable securities laws on the basis of the information in the admission document (the Admission Document ) to be published by Kitwave Group plc in connection with the placing of ordinary shares of one pence each (the Ordinary Shares ) by the C ....

North Gate , United States , United Kingdom , North Shields , North Tyneside , City Of , Henry Wilkinson , Matthew Mchale , Richard Andrews , Sarah Hollins , Greg Vardy , Gerard Murray , Paul Young , Bobbie Hilliam , David Brind , Alex Aylen , Georgina Mccooke , Stephen Steve Smith , Canaccord Genuity , Benfield Motor Group , London School Of Economics , Group Directors , Arthur Andersen , Audit Committee , Nomination Committee , Kitwave Group ,

Tetra Bio-Pharma Receives Second Compliant Rating on Inspection from Health Canada


Tetra Bio-Pharma Receives Second Compliant Rating on Inspection from Health Canada
Key milestone in the development path to commercialization of Reduvo
OTTAWA, ON / ACCESSWIRE / April 1, 2021 /
Tetra Bio-Pharma Inc. ( Tetra or the Company ) (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development announce they have received a notice of compliance for its Drug Establishment License (DEL) following an audit by the Drug GMP Inspection Program of Health Canada.
Guy Chamberland, CEO and CRO of Tetra Bio-Pharma stated, This is a critical step in the regulatory process for drug approval. Tetra s robust GMP quality management system is in place to ensure product quality and consumer safety. This Compliance rating signifies that we are one step closer to our goal of bringing Reduvo soft gel capsules to market in 2021. ....

Natalie Leroux , Tetra Bio Pharma Inc , Inspection Program Of Health Canada , Quantum Pharma Inc , Health Canada Food , Health Canada , Regulation Services Provider , Tetra Bio Pharma , Drug Establishment License , Quantum Pharma , New Drug Submission , Reduvo Soft Gel , Drug Identification Number , நடாலி லேரௌுக்ஷ , டெட்ரா உயிர் பார்மா இன்க் , ஆய்வு ப்ரோக்ர்யாம் ஆஃப் ஆரோக்கியம் கனடா , குவாண்டம் பார்மா இன்க் , ஆரோக்கியம் கனடா உணவு , ஆரோக்கியம் கனடா , ஒழுங்குமுறை சேவைகள் வழங்குநர் , டெட்ரா உயிர் பார்மா , மருந்து ஸ்தாபனம் உரிமம் , குவாண்டம் பார்மா , புதியது மருந்து சமர்ப்பிப்பு , மருந்து அடையாளம் எண் ,